Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a highly motivated PhD- or Master’s-level intern to support deployment, optimization, and validation of the FACETS pipeline. The intern will deploy, optimize, and harden the FACETS pipeline for WES and targeted panel tumor/normal datasets, automate preprocessing, segmentation, and allele-specific copy-number calling workflows, and integrate FACETS outputs into downstream pipelines.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines